and , if therapy is initiated subsequent to the establishment of estrogen-induced hyperprolactinemia and pituitary hyperplasia , bromocriptine is more effective than tamoxifen at the doses studied .
C0020514
hyperprolactinemia
C0006230
bromocriptine